Further Earnings Guidance
The Board of Directors of Medical Developments International Ltd. (ASX:MVP) advise the market that further to the excellent result announced for H1 FY12, the company has continued to deliver strong earnings growth in H2 FY12.
The Directors of MVP now advise Net Profit after Tax for FY12 is expected to be least $2.2M (FY11 $1.743M).